drugset / Trial / NCT00256555

Growth Hormone Treatment Study in Children With Cystic Fibrosis

NCT00256555

CrossoverOpen-labelTreatment

Summary

Cystic fibrosis (CF) is a catabolic condition, and children affected with this disease frequently have problems with growth, despite adequate nutrition. We hypothesize that the anabolic effects of growth hormone (GH) will improve the height and weight of CF patients and thereby improve their clinical status and their quality of life. We further hypothesize that these effects will be sustained for at least one year after GH treatment is complete.

Timeline

Start
2000-02
Primary completion
2018-12-12
Completion
2018-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.3 mg/kg

Indications